NCL  
Nanotechnology Characterization Laboratory Skip Navigation
 
Working with the NCL
Input of Nanomaterials - Evaluation Criteria - Intellectual Property - Education & Training
Application Process - Assay Cascade - NCL Nanoparticles - Material Transfer Agreement

NCL Collaborators

Please click on each logo to find out more information about their nanotech capabilities.

 
General Electric Luna Nanoworks
Alnis BioSciences

PDS Biotechnology

Avidimer Therapeutics, Inc.    Carigent    Cedars Sinai Hospital

Dendritic Nanotechnologies    CytImmune

Evident Technologies    Imperial College London

Lombardi Comprehensive Cancer Center Penn State
James R. Connor, Ph.D.
Northeastern University
Vladimir P. Torchilin, Ph.D., D.Sc.		 Tego Texas A & M university
Penn State
Mark Kester, Ph.D.		 NanoScan Imaging
Purdue university university of Pittsburgh Northeastern University
Mansoor M. Amiji, Ph.D.
University of Missouri - Columbia
UCLA  University of Wisconsin  NanoSpectra

Azaya Celator Lankenau
UCLA
Andre Nel, M.B.Ch.B., Ph.D.		 MD Anderson UCLA
Massoud Akhtari, Ph.D.


 
   Quick Guide to
Application Process
View submission procedures and evaluation criteria for NCL review of nano-materials.

Next Submission Due Date for NCL Application Materials is March 1, 2012.

       
       
Skip Footer Navigation
The NCL is part of the Advanced Technology Program, SAIC-Frederick, Inc.

Home | Text-Only Version | Contact Us | Policies | Accessibility | Viewing Files | Search | Site Map
Home | Images Version | Contact Us | Policies | Accessibility | Viewing Files | Search | Site Map

A Service of the National Cancer Institute
National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthFirstGov.govNCI - Alliance for Nanotechnology in Cancer
National Cancer Institute U.S. National Institutes of Health www.cancer.gov Nanotechnology Characterization Lab